Notable

📍 Foster City, United States🗓 Founded 2014👥 42 employees💰 Last funded Jun 2019
Notable is a clinical-stage platform therapeutic company developing a new class of precision medicines: predictive precision medicines. Notable aims to be the leader in predictive precision medicine and revolutionize the way in which patients seek and receive treatment: patient population by patient population, and cancer by cancer. By transforming historical standards of care, Notable expects to provide dramatic impact for patients and the healthcare community. Notable’s proprietary Predictive Precision Medicines Platform replicates ex vivo the clinical response of patients to cancer treatments with high fidelity, through its optimized integration of biological assay conditions, dynamic signal analysis, and AI-driven in-silico translation into predictive algorithms. Using its high-fidelity platform, Notable can identify and select clinically responsive patients prior to their treatment and fast-track clinical development in this patient population. Notable has created a targeted, triple de-risked in-licensing strategy and a fast-track clinical development approach that delivers a product’s medical impact and commercial value faster, higher, and more likely than traditional drug development.
5
Total investors
3
Early stage
2
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
United States
5
Investor activity2015–2019 · investors recorded per year
20152201612017120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Notable?
Notable has 5 investors on record on gritt.io, including 3 early-stage backers, 2 mid-stage.
When did Notable last raise funding?
The most recent investment in Notable recorded on gritt.io was in June 2019.
When was Notable founded?
Notable was founded in 2014.
What industry is Notable in?
Notable operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Notable based?
Notable is headquartered in Foster City, United States.